Company intelligence
CAS
Connecting the world's scientific knowledge to accelerate breakthroughs that improve lives.
About CAS
CAS is a leader in scientific information solutions and a division of the American Chemical Society. For over 100 years, scientists, patent professionals, and business leaders have relied on CAS to provide the hindsight, insight, and foresight needed to accelerate breakthroughs and improve lives. Scientific data is growing at a nearly exponential rate. Finding the right information quickly, avoiding missed opportunities, and getting discoveries to market faster are constant pressures. CAS employs hundreds of scientists and technologists who curate, connect, and analyze the world's published science to reveal the unseen connections that drive confident decisions and fuel innovation. Our solutions support the full R&D and IP lifecycle: - CAS Newton℠: Agentic AI built for science, with conversational access to 150+ years of interconnected scientific knowledge - CAS SciFinder Discovery Platform™: Research and discovery tools that accelerate time to market - CAS BioFinder®: Integrated chemistry and biological data for drug discovery - STN IP Protection Suite™: Patent search and competitive intelligence - CAS IP Finder: AI-enhanced intellectual property search for teams at every level - CAS Custom Services℠: Tailored data curation and knowledge management solutions - CAS Intelligence Hub: Cloud-based, AI-ready scientific data at enterprise scale We serve biotechnology, life sciences, pharmaceutical, agrochemical, consumer goods, diversified chemicals, academia, law firms, patent offices, and independent research organizations. The success of AI and machine learning in science depends on data quality. CAS has the content, technology, and human expertise to help organizations build the data foundation they need to get real returns from their R&D investments. Connect with us at cas.org.
Verified activity
Signals from CAS
12 published signals
Research & Knowledge
CAS published an analysis of 368,000+ global pharmaceutical patent filings showing that AI and ML applications now account for nearly 24% of patent filings up from just 9% in 2020.
Reported by CAS
Presence & Recognition
CAS held an expert panel recording on patent activity diversifying across therapeutic modalities and molecular targets.
Reported by CAS
Products & Services
CAS offers FIZ PatMon to track patent activities and competitive developments.
Reported by CAS
Research & Knowledge
CAS published an article in The Medicine Maker by Andrea Jacobs, Director of Artificial Intelligence, discussing curated data as the foundation for reliable drug discovery AI.
Reported by CAS
Research & Knowledge
CAS and Lilly conducted a first-of-its-kind analysis of 25 years of process chemistry data to provide empirical foundation for R&D teams.
Reported by CAS
Presence & Recognition
CAS filmed an episode of Haresh's podcast Syntinuum: Endless Evolutions during his internship.
Reported by Andrea Jacobs
People
CAS welcomed Haresh as an intern in the summer.
Reported by Andrea Jacobs
Presence & Recognition
CAS is attending the EFMC International Symposium on Medicinal Chemistry 2026 in Basel.
Reported by Elena Detta, PhD
Research & Knowledge
CAS published a new report mapping where the science is headed for polymers in EVs, water filtration, and wearable devices.
Reported by CAS
Presence & Recognition
CAS is exhibiting in booth 26 to connect SAR data, targets, and biomarkers to narrow candidates with confidence.
Reported by CAS
Presence & Recognition
CAS is facilitating a live crowdsource session at the Frost & Sullivan Innovation Workshop at Ohio State on measuring AI ROI and business impact.
Reported by Andrea Jacobs
Presence & Recognition
CAS is hosting a talk titled Technology, Talent, and Trust: Making AI Work for Science in the Real World at CIEX in Indianapolis next week.
Reported by Andrea Jacobs